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Abstract
Background: Common variants in PCSK1 have been reported to be associated with obesity in populations of European
origin. We aimed to replicate this association in Chinese.
Methodology/Principal Findings: Two PCSK1 variants rs6234 and rs6235 (in strong LD with each other, r
2=0.98) were
genotyped in a population-based cohort of 3,210 Chinese Hans. The rs6234 was used for further association analyses with
obesity and related traits. We found no significant association of rs6234 with obesity, overweight, BMI, waist circumference,
or body fat percentage (P.0.05) in all participants. However, the rs6234 G-allele showed a significant association with
increased risk of combined phenotype of obesity and overweight (OR 1.21[1.03–1.43], P=0.0193) and a trend toward
association with obesity (OR 1.25[0.98–1.61], P=0.08) in men, but not in women (P$0.29). Consistently, the rs6234 G-allele
showed significant association with increased BMI (P=0.0043), waist circumference (P=0.008) and body fat percentage
(P=0.0131) only in men, not in women (P$0.24). Interestingly, the rs6234 G-allele was significantly associated with
increased HOMA-B (P=0.0059) and decreased HOMA-S (P=0.0349) in all participants.
Conclusion/Significance: In this study, we found modest evidence for association of the PCSK1 rs6234 with BMI and
overweight in men only but not in women, which suggested that PCSK1 rs6234 might not be an important contributor to
obesity in Chinese Hans. However, further studies with larger sample sizes are needed to draw a firm conclusion.
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Introduction
The PCSK1 (prohormone convertase 1/3) gene encodes
prohormone convertase 1/3 that converts inactive prohormones
(including proinsulin, proglucagon and proopiomelanocortin) into
biologically active peptide hormones. Loss-of-function mutations
in PCSK1 gene cause monogenic obesity and impaired glucose
tolerance in human [1,2,3], implying that common variants in
PCSK1 might predispose to obesity and type 2 diabetes in the
general population. Recently, the PCSK1 nonsynonmous variants
rs6232 (encoding N221D) and rs6234-rs6235 (encoding the
Q665E-S690T pair) have been shown to be consistently associated
with obesity risk (OR=1.34 and 1.22, respectively) in European
populations including a total of 13,659 individuals from eight
independent case-control or family-based cohorts [4]. However,
only a modest evidence for association between body mass index
(BMI) and the PCSK1 variant rs6232 (P=0.03) was found in a
meta-analysis of 15 genome-wide association studies (GWAS) for
BMI with 32,387 individuals of European origin [5]. A subsequent
study in 3,885 non-diabetic Swedes failed to confirm the
association between the PCSK1 rs6235 and obesity [6]. Similarly,
another recent study in 20,249 individuals of European descents
from Norfolk, UK, also failed to replicate the association of the
PCSK1 rs6235 with obesity and related traits, and only found a
suggestive evidence for association of the PCSK1 rs6232 with
obesity and BMI in younger individuals (age ,59 yrs) but not in
older age group [7]. Due to the inconsistent results, further
replication studies are essential to confirm the association between
genetic variation in PCSK1 and obesity, particularly in other ethnic
populations. In this study, we aimed to examine whether the
previously reported association of the PCSK1 genetic variants with
obesity and related traits could be replicated in a population-based
cohort of Chinese Hans including 3,210 unrelated individuals
from Beijing and Shanghai.
Materials and Methods
Study population
The study sample consisted of 3,210 individuals (1,423 men and
1,787 women) from the Study on Nutrition and Health of Aging
Population in China, a population-based study among non-
institutionalized and unrelated Chinese Hans aged 50 to 70 years
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protocols have been described in detail elsewhere [8]. Height,
weight, waist circumference and body fat percentage, as well as
fasting glucose and insulin were measured following standard
protocols as described previously [8]. Homeostasis model
assessment of pancreatic beta-cell function (HOMA-B) and insulin
sensitivity (HOMA-S), as measures of beta-cell function and
insulin sensitivity, respectively, were estimated by the homeostasis
model using Levy’s computer model [9]. Normal weight,
overweight and obesity were defined as BMI ,24, 24# BMI
#28 and BMI $28 kg/m
2, respectively, according to the Chinese
criteria [10]. The study was approved by the Institutional Review
Board of the Institute for Nutritional Sciences, Shanghai, China,
with written informed consent from all participants. The
phenotypic characteristics of the population are shown in Table 1.
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes
by salting out procedure (http://www.protocol-online.org/prot/
Detailed/3171.html). Single nucleotide polymorphism (SNP)
genotyping was performed with TaqMan SNP allelic discrimi-
nation by the ABI PRISM 7900HT Sequence Detection System
(Applied Biosystems) according to the manufacturer’s protocol.
Since the PCSK1 rs6232 is largely monomorphic in Chinese
(minor allele frequency [MAF]=0.01 and 0 for HapMap-CHB
sample and AFD_CHN_PANEL, respectively), only the rs6234
and rs6235 were successfully genotyped in this study. The
genotyping success rates of the rs6234 and rs6235 were 98.5%
and 98.3%, respectively, and the concordance rates were both
.99.5% based on 12% duplicate samples (n=384). The allele
frequencies of both SNPs (MAF=0.330 and 0.328 for rs6234 and
rs6235 in current sample, respectively) were comparable to those
in the HapMap HCB database, and in Hardy-Weinberg
equilibrium (P.0.54). Since these 2 SNPs were in almost
complete linkage disequilibrium (LD) (r
2=0.98 in this population
and r
2=1 in HapMap-CHB population), only the rs6234 was
selected for further association analyses as it had a higher
genotyping success rate.
Statistical analysis
The association between the rs6234 and risk of overweight,
obesity and type 2 diabetes was tested by logistic regression under
an additive model, adjusting for age, gender, geographical region
(Shanghai/Beijing) and BMI (where appropriate). Generalized
linear regression was applied to test for association between the
rs6234 and quantitative traits in which participants with known
diabetes or receiving glucose-lowering treatment (n=267) were
excluded. BMI, waist circumference, insulin and HOMA-S were
natural log-transformed before analyses. Since the SNP distribu-
tion was not different between geographical regions (P.0.88), we
pooled all 3,210 individuals for the association studies. SNP-
gender and SNP-age (,60 yrs, and .60 yrs) interactions were
assessed by including the respective interaction term in the
regression models. LD was estimated using Haploview V3.2
(http://www.broad.mit.edu/mpg/haploview). All reported P-val-
ues are nominal and two-sided. Association analyses were
performed with SAS version 9.1 (SAS Institute, Cary, North
Table 1. Characteristics of the study population.
Men Women All
N (%) 1,423 (44.3) 1,787 (55.7) 3,210
Age (year) 58.865.9 58.466.1 58.666.0
BMI (kg/m
2) 24.0 (21.8–26.3) 24.5 (22.1–26.9) 24.2 (22.0–26.6)
Waist circumference
(cm)
85.6 (78.0–92.7) 81.7 (74.9–89.0) 83.5 (76.0–90.8)
Body fat percentage
(%)
a
20.465.4 32.565.3 27.568.0
Fasting glucose
(mmol/L)
5.9561.89 5.7461.59 5.861.74
Fasting insulin
(pmol/L)
74.4 (52.8–102.0) 88.2 (64.8–119.4) 82.2 (59.4–112.2)
HOMA-B (%) 101.6645.6 117.2646.9 110.3647.0
HOMA-S (%) 69.5 (51.1–96.6) 59.3 (44.6–81.1) 63.6 (47.1–86.9)
Overweight (%) 531 (37.3) 693 (38.7) 1224 (38.1)
Obese (%) 177 (12.4) 297 (16.6) 474 (14.8)
IFG (%) 425 (29.9) 453 (25.4) 878 (27.4)
Type 2 diabetes (%) 207 (14.6) 217 (12.1) 424 (13.2)
Data are n (%), means6SD or medians (interquartile range).
BMI, body mass index; HOMA-B, homeostasis model assessment of pancreatic
beta-cell function; HOMA-S, homeostasis model assessment of insulin
sensitivity; IFG, impaired fasting glucose.
aBody fat percentage (%) was assessed using the dual-energy X-ray
absorptiometry (DEXA) among 1,634 participants (711 men and 923 women)
from Shanghai.
doi:10.1371/journal.pone.0010590.t001
Table 2. Case-control analyses of PCSK1 rs6234 with obesity and overweight.
Major/minor
allele Obesity vs. Normal Obesity and overweight vs. Normal
n/MAF OR (95% CI) P n/MAF OR (95% CI) P
Cases Controls Cases Controls
All C/G 471/0.321 1489/0.319 1.02 (0.86–1.19) 0.86 1674/0.339 1489/0.319 1.10 (0.98–1.22) 0.10
Men 176/0.366 703/0.312 1.25 (0.98–1.61) 0.08 696/0.360 703/0.312 1.21 (1.03–1.43) 0.0196
Women 295/0.293 786/0.324 0.89 (0.72–1.10) 0.29 978/0.324 786/0.324 1.02 (0.88–1.18) 0.82
P for
interaction
0.0458 0.11
The ORs are odds ratios that represent the effects of risk allele (G-allele) based on an additive model, in which individuals homozygous for CC were coded as 0,
heterozygous individuals CG were coded as 1, and individuals homozygous for GG were coded as 2; The ORs and P values were adjusted for age, region and sex (where
appropriate).
MAF, minor allele frequency.
doi:10.1371/journal.pone.0010590.t002
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software (http://hydra.usc.edu/gxe/).
Results
We found no significant association between PCSK1 rs6234 risk
G-allele and obesity or overweight among all participants (P$0.10)
(Table 2). However, the PCSK1 rs6234 G-allele showed a
significant association with increased risk of combined phenotype
of obesity and overweight (OR 1.21[1.03–1.43], P=0.0193) (P for
SNP-gender interaction =0.11) and a trend toward association
with increased obesity risk (OR 1.25[0.98–1.61], P=0.08) (P for
SNP-gender interaction =0.0458) in men, but not in women
(P$0.29) in the gender-stratified analyses (Table 2). Consistently,
the rs6234 G-allele was significantly associated with increased BMI
(P=0.0043) (P for SNP-gender interaction =0.0045), waist
circumference (P=0.008) (P for SNP-gender interaction =
0.0055) and body fat percentage (P=0.0131) (P for SNP-gender
interaction =0.08) only in men, whereas no associations were
observed in women (P$0.24). Our study had only 72.5% power to
detect OR=1.22 for obesity, as previously reported by the original
study [4], at a significance of 5% and a MAF $34%. We,
therefore, cannot rule out the possibility of false negative findings
in women. In addition, no SNP-age interactions on risk of obesity
or overweight or related traits were observed.
We observed no association with the risk of type 2 diabetes or
combined type 2 diabetes/IFG either in all individuals or in men
and women separately (P.0.50) (data not shown). In quantitative
traits analyses, the rs6234 G-allele was significantly associated with
increased HOMA-B (P=0.0059) and decreased HOMA-S
(P=0.0349), but not with fasting glucose (P=0.93). No SNP-
gender interactions (P$0.16) were observed (Table 3).
Discussion
In this population-based sample of Chinese Hans, we did not
replicate the association between the PCSK1 rs6234-rs6235 pair and
obesity risk previously reported by original study in European
p o p u l a t i o n s[ 4 ] .T h i si sc o n s i s t e n tw i t hf i n d i n g so fs e v e r a lr e c e n t
studies including 2 independent GWAS in White Europeans, in
which no association was found between the PCSK1 rs6235 and
obesity or BMI [5,6,7,11]. Interestingly, we found that the PCSK1
rs6234 risk G-allele was marginally associated with obesity and
significantly associated with combined obesity/overweight in men,
but not in women when the analyses were stratified by gender.
Consistently, the same risk allele was also significantly associated with
increased BMI and waist circumference in men in the quantitative
trait analyses, but not in women, with significant SNP-gender
interactions on BMI (P for interaction =0.0045) and waist
circumference (P for interaction =0.0055). This is the first study to
report the significant SNP-gender interactions of the PCSK1 rs6234
on obesity related traits in Chinese Hans. We therefore choose to
report all the results for men and women separately to highlight all
potentially useful associations for subsequent studies. However, two
previous replication studies in populations of European origin did not
find any SNP-gender interaction of the PCSK1 rs6235 on obesity risk
[6,7]. Moreover, a more recent study in 1,094 subjects of Chinese
origin has suggested that a common variant (rs155791) in strong LD
with the rs6235 and rs6234, and two common haplotypes were all
associated with obesity [12]. Lack of replication of the previously
reported association in women could be because of limited power of
this current study. Nevertheless, further studies with larger sample
sizes would be required to provide definite evidence for the
association between common variants in PCSK1 and obesity in
Chinese Hans.
Another interesting finding of the present study is that the
PCSK1 rs6234 G-allele was significantly associated with decreased
insulin sensitivity and increased beta-cell function estimated by
HOMA-S and HOMA-B, respectively. The underlying mecha-
nism remained to be investigated. Consistently, the recent study in
a Chinese population has also found a suggestive evidence for
association between the PCSK1 rs6235 and increased HOMA-IR
values (P=0.02) [12]. The compensatory adaptation of pancreatic
beta-cells to insulin resistance might lead to increased HOMA-B.
However, more studies are warranted to confirm this hypothesis.
In conclusion, in this population-based cohort of Chinese Hans,
we found modest evidence for association of the PCSK1 variant
rs6234 with BMI and overweight in men only, but not in women.
Table 3. Quantitative traits analyses of PCSK1 rs6234 with
obesity related traits.
PCSK1 rs6234
CC CG GG P
P for
interaction
BMI (kg/m
2)
ab
All 24.0 (0.1) 24.1 (0.1) 24.2 (0.2) 0.45 0.0045
Men 23.5 (0.1) 23.9 (0.1) 24.3 (0.3) 0.0043
Women 24.5 (0.1) 24.4 (0.1) 24.1 (0.3) 0.26
Waist circumference (cm)
ab
All 82.8 (0.3) 83.1 (0.3) 83.2 (0.6) 0.49 0.0055
Men 83.8 (0.4) 85.9 (0.4) 86.8 (0.8) 0.008
Women 81.5 (0.4) 81.3 (0.4) 80.6 (0.8) 0.24
Body fat percentage (%)
b
All 26.060.2 26.760.3 26.760.5 0.06 0.08
Men 19.760.4 20.860.4 21.560.8 0.0131
Women 32.360.3 32.760.3 32.260.6 0.72
Glucose (mmol/L)
c
All 5.5760.03 5.6260.03 5.5360.07 0.93 0.79
Men 5.6260.05 5.6860.05 5.5960.11 0.83
Women 5.5260.04 5.5660.04 5.4760.09 0.93
Insulin (pmol/L)
ac
All 77.9 (1.1) 81.8 (1.1) 79.0 (2.2) 0.09 0.31
Men 71.5 (1.5) 73.7 (1.5) 70.4 (3.1) 0.83
Women 83.2 (1.4) 89.1 (1.6) 86.1 (3.1) 0.0441
HOMA-B (%)
c
All 111.161.2 114.461.2 117.662.5 0.0059 0.16
Men 105.561.8 105.561.8 109.963.7 0.43
Women 116.961.6 122.861.6 125.263.3 0.0032
HOMA-S (%)
ac
All 67.6 (0.9) 64.4 (0.8) 65.6 (1.8) 0.0349 0.61
Men 72.5 (1.5) 71.0 (1.4) 70.0 (2.9) 0.37
Women 63.9 (1.1) 59.4 (1.0) 62.4 (2.2) 0.0492
Data are means6SE or geometric means (SE) unless otherwise indicated;
Participants previously diagnosed type 2 diabetes or receiving anti-glucose
treatment (n=267) were excluded from the analyses.
BMI, body mass index; HOMA-B, homeostasis model assessment of pancreatic
beta-cell function; HOMA-S, homeostasis model assessment of insulin
sensitivity.
aThese variables were log-transformed before analyses.
bAdjusted for age, region and sex (where appropriate).
cAdjusted for age, region, BMI and sex (where appropriate).
doi:10.1371/journal.pone.0010590.t003
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the association between common variants in PCSK1 and obesity
risk in Chinese Hans, especially in women.
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